Buy Like Buffett
Watchlist

Flagship explainer

How KYNTRA BIO, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$6.4M · 100%Cost of revenue$556000 · 9%Gross profit$5.9M · 91%Operating income−$45.9M · −713%Income before tax−$58.3M · −905%Income tax−$90000 · −1%Net income$183M · 2849%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$6.4M100%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
Cost of revenue$5560009%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
$5.9M91%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
−$45.9M−713%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
Income before tax−$58.3M−905%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
Income tax−$90000−1%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
$183M2849%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-108346 · filed Mar 16, 2026
· event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full KYNTRA BIO, INC. analysis at Buy Like Buffett

KYNB income explainer — Buy Like Buffett · Buy Like Buffett